Rosetta Genomics Ltd (NASDAQ:ROSG)

2.98
Delayed Data
As of Mar 27
 -0.075 / -2.46%
Today’s Change
2.07
Today|||52-Week Range
5.55
+31.64%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Rosetta Genomics Ltd have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate represents a +34.45% increase from the last price of 2.98.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Hold stock in Rosetta Genomics Ltd. This rating has held steady since March, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.35
Sales
$150.0K
Reporting Date
Nov 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 2.78%
 
 
 
 
 
 
Growthannually -179.75%
 
 
 
 
 
 

Sales

Growthquarterly 50.00%
 
 
 
 
 
 
Growthannually 282.03%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account